Radiological and clinical improvement in a patient with COVID-19 pneumonia postconvalescent plasma transfusion: A case report
Abstract: Currently, there are no approved specific antiviral agents for novel coronavirus disease 2019 (COVID-19). Convalescent plasma has not yet been approved for use in patients with COVID-19 infection; however, it is regulated as an investigational product. This is a case report of a 55-year-old male, with COVID-19 pneumonia who has received convalescent plasma as part of a treatment plan which showed significant radiological and clinical improvement post-treatment.
Keywords: COVID-19 / RT-PCR / Convalescent plasma transfusion / Groung-glass opacities / Crazy paving appearance / CT, computed tomography / CECT, COVID-19, coronavirus disease 2019 / RT-PCR, Reverse transcription polymerase chain reaction / ED, emergency department / NC, nasal cannula / CRP, C-reactive protein / ICU, intensive care unit / HRCT, high-resolution computed tomography / CXR, chest x-ray / AJR, American Journal of Roentgenology / ACR, American College of Radiology
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Click here to see the statistics on "Radiology Case Reports" .